Open Access

Metastatic follicular thyroid carcinoma to the mandible: a case report

  • Sumairi Bin Ismail1,
  • Mannil Thomas Abraham2,
  • Zuraiza Binti Zaini3,
  • Hashim Bin Yaacob3 and
  • Rosnah Binti Zain3Email author
Cases Journal20092:6533

https://doi.org/10.1186/1757-1626-2-6533

Received: 20 November 2008

Accepted: 17 February 2009

Published: 29 April 2009

Abstract

Introduction

Metastatic lesions to the oro-facial region may be the first evidence of dissemination of an unknown tumour from its primary site.

Case presentation

We described a case of metastatic follicular thyroid carcinoma to the mandible presenting with pain and loosening of teeth in a 70 years old female patient leading to extraction of the loose teeth.

Conclusion

The present case emphasizes the importance of considering metastasis in the differential diagnosis of swelling related to loosening of teeth, even though the patient had no history of any malignant disease.

Introduction

Metastatic carcinomas to oral region constitute approximately one percent of all oral malignancies. Breast, lung, adrenal, kidney, gastrointestinal tract and prostate are the most common sites for primary tumor from which metastasis occurs [1, 2]. Metastatic tumours to the jaw bones are more frequently reported than those in the oral mucosa. The body of the mandible especially the premolar-molar region is the most common site of metastasis in the oral cavity [1, 3]. Pain and/or paraesthesia are the most common clinical symptoms. Thyroid carcinoma metastasizes to the jaw is extremely rare accounting about 3.85% of all jaws metastases [2]. Arriving to a diagnosis is a challenge for this case as there is no previous history of a malignant disease.

Case presentation

A 70-year-old Malay female patient reported to the outpatient department of Oral and Maxillofacial Department, Tengku Ampuan Rahimah Hospital, Klang with a complaint of pain and swelling in the left side of the angle of the mandible. She had noticed the swelling three months previously and it had increased gradually to the present size. Three months earlier she had undergone extraction of the left mandibular second premolar for complaints of mobility and pain. She also complained of bouts of nausea and vomiting for the past 1 to 2 months with loss of appetite. The medical history revealed that the patient is been treated for hypertension and diabetes with no history of malignancy. There was no history of smoking, alcohol consumption or betel quid chewing.

On examination, a firm, swelling of size 3 to 4 cm was noticed in left side of the mandible, distal canine region extending to the second molar and involving the buccal sulcus at the canine region (Figure 1). On palpation, bicortical expansion of the body of the mandible was noted. Intraorally, there was an erythematous change over the region and adjacent buccal mucosa. No submandibular lymph nodes were palpable. Radiographic examination and 3-dimensional CT (computed tomography) scan showed a lesion of the left body of mandible extending from the lower left canine region to second molar region with diffuse margin leaving lower border intact (Figure 2).
Figure 1

Swelling of the left gingival area. An intra-oral photograph showing the metastatic lesion at gingiva of the left mandibular premolar and molar area

Figure 2

A 3-Dimentional CT scan. A three dimensional CT scan showing the metastatic lesion

An incisional biopsy was performed. The histopathological examination revealed thyroid follicles filled with colloid material (Figure 3) which is positive for PAS stain. The cells surrounding the follicles were intensely positive for thyroglobulin. The interpretation was metastatic follicular carcinoma of the thyroid.
Figure 3

Histopathology of The Metastatic Lesion. A photomicrograph showing well-differentiated thyroid follicles with abundant colloid (H&E; Original magnification-20X)

Subsequent coronal CT scan of the neck was done showing a mass in the right thyroid region. Chest radiograph and axial CT scan were also taken which showed metastatic lesion and enlarged hilar lymph nodes.

Discussion

Because of their rarity, metastatic tumours to the oral region are difficult to diagnose. The most common primary sites are the breast (21.8%) followed by lung (12.6%), adrenal (8.7%), kidney (7.9%), bone (7.4%), colo-rectum (6.6%) and prostate (5.6%) [2]. Most metastatic tumours to the oral region occur in patients aged 40 to 70 years [1, 3].

Metastatic tumours are of great significance since some cases may represent the only symptom of an undiscovered underlying malignancy. In one third of patients, oral metastasis may be the first evidence of metastasis from its primary site [1]. In the jaw, pain, swelling, loosening of tooth and paraesthesia are the most common clinical manifestations [1, 3]. Patient complaining of numb chin or mental nerve neuropathy should always raise the possibility of a metastatic disease in the mandible. A peculiar site for metastasis is the post extraction site. Hirshberg et al. reported 55 cases out of 390 cases, in which tooth extraction preceded the discovery of the metastasis [2]. The most common radiographic presentation is a radiolucent lesion with ill-defined margins. However, in approximately 5% of cases, pathological changes are not detected radiographically [2].

Follicular thyroid carcinoma (FTC) is a well-differentiated tumour which originates in follicular cells and resembles the normal microscopic pattern of the thyroid. It is the second most common cancer of the thyroid after papillary carcinoma [4]. Immunohistochemical marker for FTC is thyroglobulin, which is present in more than 95% of follicular thyroid carcinoma [5].

Distant metastases occur in 10 to 15% of patients with differentiated thyroid carcinoma [6]. Bone metastasis is the second most common site of metastasis after lung. Bone metastasis are found in 1 to 3 percent of well-differentiated thyroid carcinomas, occurring more often in follicular carcinoma and in patients more than 40 years of age [7]. Follicular thyroid carcinoma rarely gives rise to oral metastasis. The other reported sites in the oral region were parotid gland [8], tongue and labial mucosa [9].

The optimal therapy for differentiated thyroid cancer includes thyroidectomy and radiotherapy. The presence of distant metastases is associated with poor prognosis. An overall 10-year survival rate of 27% for bone metastasis of differentiated thyroid carcinoma has been reported [10]. Brennan et al. reported 40% survivors of distant follicular metastases after 5 years [11]. An early detection of metastatic disease improves the overall survival rate and treatment results.

Consent

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

List of abbreviations

FTC: 

Follicular thyroid carcinoma

CT: 

Computed tomography.

Declarations

Acknowledgements

The authors thank Dr. Julia Woolgar, Senior Lecturer/Honorary Consultant in Oral Pathology, University of Liverpool and Dr. Wan Himratul Azna Wan Harun, Department of Pathology, Putrajaya Hospital for their diagnostic contribution.

Authors’ Affiliations

(1)
Department of Oral Pathology & Oral Medicine, Hospital Sultan Abdul Halim
(2)
Department of Oral & Maxillofacial Surgery, Hospital Tengku Ampuan Rahimah, Ministry of Health
(3)
Oral Cancer Research and Coordinating Centre (OCRCC), and Department of Oral Pathology, Oral Medicine and Periodontology, Faculty of Dentistry, University of Malaya

References

  1. van der Waal RIF, Buter J, van der Waal I: Oral metastases: report of 24 cases. Brit J Oral Maxillofacial Surg. 2003, 41: 3-6. 10.1016/S0266-4356(02)00301-7.View ArticleGoogle Scholar
  2. Hirshberg A, Leibovich P, Buchner A: Metastatic tumors to the jawbones: analysis of 390 cases. J Oral Pathol Med. 1994, 23: 337-341. 10.1111/j.1600-0714.1994.tb00072.x.View ArticlePubMedGoogle Scholar
  3. Hirshberg A, Buchner A: Metastatic tumours to the oral region. An overview. Eur J Cancer B Oral Oncol. 1995, 31B: 355-360. 10.1016/0964-1955(95)00031-3.View ArticlePubMedGoogle Scholar
  4. Gilliland FD, Hunt WC, Morris DM, Key CR: Prognostic factors for thyroid carcinoma: A population-based study of 15, 698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer. 1997, 79: 564-573. 10.1002/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO;2-0.View ArticlePubMedGoogle Scholar
  5. Tatic S: Histopathological and immunohistochemical features of thyroid carcinoma. Archive of Oncology. 2003, 11: 173-174. 10.2298/AOO0303173T.View ArticleGoogle Scholar
  6. Hoie J, Stenwig AE, Kullmann G, Lindegaard M: Distant metastases in papillary thyroid carcinoma: a review of 91 patients. Cancer. 1988, 61: 1-6. 10.1002/1097-0142(19880101)61:1<1::AID-CNCR2820610102>3.0.CO;2-R.View ArticlePubMedGoogle Scholar
  7. Mizukami Y, Michigishi T, Nonomura A: Distant metastases in differentiated thyroid carcinomas: a clinical and pathologic study. Human Pathology. 1990, 21: 283-290. 10.1016/0046-8177(90)90228-W.View ArticlePubMedGoogle Scholar
  8. Markitziu A, Fisher D, Marmary Y: Thyroid papillary carcinoma presenting as jaw and parotid gland metastases. Int J Oral Maxillofac Surg. 1986, 15: 648-653. 10.1016/S0300-9785(86)80074-6.View ArticlePubMedGoogle Scholar
  9. Whitaker B, Robinson K, Hewan-Lowe K, Budnick S: Thyroid metastasis to the oral soft tissues: case report of a diagnostic dilemma. J Oral Maxillofac Surg. 1993, 51: 588-593. 10.1016/S0278-2391(10)80521-X.View ArticlePubMedGoogle Scholar
  10. Schlumberger M, Tubiana M, De Vathair. F: Long term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab. 1986, 63: 960-967. 10.1210/jcem-63-4-960.View ArticlePubMedGoogle Scholar
  11. Brennan MD, Bergstralh EJ, van Heerden JA, McConahey WM: Follicular thyroid cancer treated at the Mayo Clinic, through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc. 1991, 166: 11-22.View ArticleGoogle Scholar

Copyright

© Ismail et al; licensee Cases Network Ltd. licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement